Nucleon Nutrition Retatrutide 5 mg – Triple Receptor Agonis

Nucleon Nutrition Retatrutide 5 mg is an innovative research peptide that has garnered significant attention in metabolic and body-weight regulation studies. What sets Retatrutide apart is its unique triple receptor agonist mechanism, simultaneously targeting GLP-1, GIP, and glucagon receptors. This robust approach is on the forefront of metabolic research, offering new avenues for exploration.

Unlike traditional compounds that act on a solitary pathway, Retatrutide allows scientists to investigate the combined hormonal signaling mechanisms related to:

• appetite and satiety regulation,
• glucose metabolism and the insulin response,
• energy expenditure and adipose tissue assimilation.

This triple-pathway approach provides a platform for profound insights into synergistic metabolic regulation, positioning Retatrutide as one of the most groundbreaking peptides available in the research chemical arena today.

Important: This product is sold strictly as a Research Chemical.
Not for human or animal consumption.
Intended exclusively for laboratory and scientific research purposes.

Composition

Form: Lyophilized powder (vial)
Active compound: Retatrutide

Package / Serving

Package: 1 vial
Content: 5 mg per vial

Active Ingredients

Active ingredients (per vial):

• Retatrutide – 5 mg

Nutritional Value

Not applicable – this product is not a food or dietary supplement.

4 Key Research Advantages

• Triple receptor agonist profile (GLP-1 / GIP / glucagon) for advanced metabolic studies.
• Supports research on appetite and satiety signaling pathways.
• Suitable for investigations related to glucose regulation and insulin response.
• Enables exploration of energy expenditure and fat metabolism mechanisms.

Intended Use

For research and laboratory use only.
Not intended for human or animal use.
Used exclusively by qualified professionals following proper laboratory protocols and safety standards.

For further information on the efficacy and mechanisms of Retatrutide, you can refer to the following studies: Retatrutide, a Triple Hormone Receptor Agonist, for Obesity, Efficacy and safety of retatrutide in patients with type 2 diabetes, and Triple hormone receptor agonists: a new era in obesity treatment.